ticagrelor

Ukraine

Drugs containing this active substance

  • AGRETA

    The drug is prescribed for adults to prevent atherothrombotic events (such as myocardial infarction, stroke, or death from cardiovascular causes) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of developing similar complications. It should be taken together with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Farmak JSC

  • The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or after a myocardial infarction (in combination with acetylsalicylic acid).

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: Farmak JSC

  • The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: AstraZeneca AB (manufacturing of tablets, testing, packaging of medicinal product, batch release)

  • The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: AstraZeneca AB (manufacturing of tablets, testing, packaging of medicinal product, batch release)

  • The drug is prescribed to adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of atherothrombotic events.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: AstraZeneca AB (manufacturing of tablets, testing, packaging of medicinal product, batch release)

  • The drug is prescribed to adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: AstraZeneca AB (manufacturing of tablets, testing, packaging of medicinal product, batch release)

  • The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of atherothrombotic events. It should be taken together with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: Pharmaceutical Plant "Polpharma" S.A.

  • The drug is prescribed for adults to prevent cardiovascular events (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of atherothrombotic events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Pharmaceutical Plant "Polpharma" S.A.

  • The drug is prescribed for adults to prevent cardiovascular complications (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or after a myocardial infarction with a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: Anorra Pharma Private Limited

  • The drug is prescribed for adults to prevent cardiovascular complications (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrence. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Anorra Pharma Private Limited

  • The drug is intended for adults with acute coronary syndrome or for patients who have already experienced myocardial infarction and are at high risk of recurrent cardiovascular complications. It is used in combination with acetylsalicylic acid to prevent atherothrombotic complications.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Atlantic Pharma Producoes Farmaceuticas S.A.

  • The drug is prescribed for adults to prevent cardiovascular events (such as myocardial infarction, stroke, or death) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of atherothrombotic events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: Pharos MT Limited (full-cycle manufacturing)

  • The drug is prescribed for adults to prevent cardiovascular events (such as myocardial infarction, stroke, or death) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken in conjunction with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Pharos MT Limited (full-cycle manufacturing)

  • The drug is prescribed for adults for the prevention of cardiovascular events (death from cardiovascular disease, myocardial infarction, or stroke) in cases of acute coronary syndrome or if there is a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: Genepharm S.A.

  • The drug is indicated for adults to prevent cardiovascular events (such as myocardial infarction, stroke, or death) in cases of acute coronary syndrome or in patients with a history of myocardial infarction who are at high risk of atherothrombotic events. It should be taken in conjunction with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, batch control and batch release)

  • The drug is prescribed for adults for the prevention of cardiovascular events (death from cardiovascular disease, myocardial infarction, or stroke) in cases of acute coronary syndrome or if there is a history of myocardial infarction and a high risk of further complications. It should be taken together with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Genepharm S.A.

  • The drug is prescribed for adults to prevent cardiovascular complications (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 60 mg

    ATC: B01AC24

    Manufacturer: Interkhim Limited Liability Partnership

  • The drug is prescribed for adults to prevent cardiovascular complications (death, myocardial infarction, or stroke) in cases of acute coronary syndrome or in patients with a history of myocardial infarction and a high risk of recurrent events. It should be taken concurrently with acetylsalicylic acid.

    Form: tablets, film-coated

    Active substance Dosage
    ticagrelor 90 mg

    ATC: B01AC24

    Manufacturer: Interkhim Limited Liability Partnership